Teva Pharmaceutical Industries said a European Medicines Agency (EMA) panel on Friday recommended approving migraine treatment Ajovy, a drug that the company has been counting on to revive its fortune.
from Reuters: Health News https://reut.rs/2ScZl1x
No comments:
Post a Comment